Vaccinex, Inc.
1895 Mount Hope Avenue
Rochester, New York 14620
April 12, 2024
VIA EDGAR
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Vaccinex, Inc. |
Registration Statement on Form S-3
Filed April 2, 2024
File No. 333-278467
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Vaccinex, Inc. hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-3 (the “Registration Statement”) and declare the Registration Statement effective as of 4:30 p.m., Eastern Time, on April 16, 2024, or as soon thereafter as possible.
Please feel free to direct any questions or comments concerning this request to Nick Hoover of Hogan Lovells US LLP at (410) 659-2790, and once the Registration Statement has been declared effective, please notify Mr. Hoover by calling him at the same phone number.
| Very truly yours, | ||
| Vaccinex, Inc. | ||
| /s/ Jill Sanchez | ||
| By: | Jill Sanchez | |
| Title: | Chief Financial Officer | |